Page last updated: 2024-12-11
1,25-dihydroxy-16-ene-vitamin d3
Description
You're likely referring to **1α,25-dihydroxyvitamin D3**, also known as **calcitriol**. It's not 1,25-dihydroxy-16-ene-vitamin D3.
Here's why 1α,25-dihydroxyvitamin D3 is important for research:
* **Active form of vitamin D:** Calcitriol is the biologically active form of vitamin D. It's produced in the kidneys from inactive forms of vitamin D (like cholecalciferol, or vitamin D3) and plays a crucial role in calcium homeostasis.
* **Bone health:** Calcitriol is essential for bone health. It increases calcium absorption in the gut, promotes bone mineralization, and helps regulate bone remodeling.
* **Cell signaling:** Calcitriol acts as a hormone, binding to vitamin D receptors (VDRs) located on various cells throughout the body. This interaction triggers various signaling pathways involved in diverse cellular functions.
* **Immune system:** Calcitriol plays a role in regulating immune responses. Studies suggest it can modulate the activity of immune cells like T cells and macrophages, influencing both the suppression and stimulation of inflammatory responses.
* **Other roles:** Research suggests that calcitriol may be involved in regulating cell growth and differentiation, blood pressure, and even the development of certain cancers.
**Why it's important for research:**
1. **Understanding vitamin D deficiency:** Researchers study calcitriol to better understand vitamin D deficiency and its effects on bone health, immune function, and overall health.
2. **Therapeutic potential:** Due to its various roles, calcitriol is being investigated for its potential therapeutic applications in conditions like:
* **Osteoporosis:** To increase bone density and reduce fracture risk.
* **Autoimmune diseases:** To modulate immune responses in conditions like rheumatoid arthritis and multiple sclerosis.
* **Cancer:** To potentially inhibit cancer cell growth and promote tumor regression.
* **Other conditions:** Such as cardiovascular diseases, inflammatory bowel disease, and certain skin conditions.
3. **Understanding vitamin D metabolism:** Research on calcitriol helps scientists understand the complex pathways involved in vitamin D synthesis, activation, and inactivation.
**Important Note:** It's crucial to consult a healthcare professional before taking any vitamin D supplements, as high levels of calcitriol can be toxic.
Research into 1α,25-dihydroxyvitamin D3 is ongoing, and its potential for treating various conditions is still under investigation.
1,25-dihydroxy-16-ene-vitamin D3: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 6439178 |
MeSH ID | M0232046 |
Synonyms (6)
Synonym |
1,25-dihydroxy-16-ene-vitamin d3 |
1,25-(oh)2-16-ene-d3 |
(1r)-5-[(2e)-2-[(3as,7as)-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3h-inden-4-ylidene]ethyl]-6-methylidenecyclohex-3-ene-1,3-diol |
124409-58-1 |
(1alpha,3beta,5z,7e)-9,10-secocholesta-3,7,10(19),16-tetraene-1,3,25-triol |
9,10-secocholesta-3,7,10(19),16-tetraene-1,3,25-triol, (1alpha,3beta,5z,7e)- |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.25 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |